This study gives an insight into Global Stents and Biodegradable Stents market. The report also provides an overview of the Worldwide Bare Metal Stents and Drug Eluting Stents market. Market analytics for Biodegradable Stents by Application and by Biodegradable Material is provided in this niche report. The market is divided by Application into Coronary Arterial Stents, Peripheral Arterial Stents and Other; and by Biodegradable Material into Polymer and Metal. Global stents market is analyzed from 2005 -2015, while estimations and predictions for biodegradable stents market are provided from 2015-2020. Key market dynamics are provided for North America, Europe, Asia-Pacific, and Rest of World (RoW). Business profiles of 25 biodegradable stents companies are discussed in the report. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report.
Table of Content 1. SCOPE AND METHODOLOGY 1 2. REPORT SYNOPSIS 3 2.1 Introduction 3 Types of Stents 3 Bare-Metal Stents 4 Drug Eluting Stents (DES) 4 Everolimus 5 Sirolimus 5 Biolimus A9 5 Pimecrolimus 6 Biodegradable Stents 7 Raw Materials 7 Polymeric Stents 7 Degradation of Biodegradable Polymers 8 Processing of Biodegradable Polymers 9 Role of Biodegradable Polymers 9 In Tissue Engineering 9 In Controlling Drug Delivery 9 Application 10 Polymer based Stents 10 Igaki-Tamai Stent 10 ReZolve Stent 10 Metal Stents 11 Bioabsorbable Metal based Stents 12 Magnesium Stents 12 Applications of Biodegradable Stents 12 2.2 Segmentation 13 Exhibit 1. Segmentation of Biodegradable Stents Market by Application Area (2015 - 2020) 13 2.3 Stents - Global Market Analysis 14 Exhibit 2. Stents - Global Value Market Estimations & Predictions (2005 -2020) in US$ Billion 14 2.3 Biodegradable Stents - Global Market Analysis 15 Exhibit 3. Biodegradable Stents - Global Value Market Estimations & Predictions (2015 -2020) in US$ Million 15 Exhibit 4. List of Global Major Companies in Biodegradable Stents Market 15 3. MARKET DYNAMICS 17 3.1 Global Biodegradable Stents Market 17 Exhibit 5. Biodegradable Stents – Global Value Market Estimations & Predictions (2015 -2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million 17 Exhibit 6. Biodegradable Stents – Global Value Market Shares (2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World 18 Exhibit 7. Biodegradable Stents – Global Value Market Estimations & Predictions (2015 -2020) by Application Area for Coronary Arterial Disease, Peripheral Arterial Disease and Other in US$ Million 19 Exhibit 8. Biodegradable Stents – Global Value Market Shares (2015 & 2020) by Application Area for Coronary Arterial Disease, Peripheral Arterial Disease and Other 20 3.4 Biodegradable Stents - Major Company Profiles 21 480 Biomedical (USA) 21 Abbott Vascular (USA) 22 American Medical Systems, Inc. (USA) 23 Arterial Remodeling Technologies (ART) (France) 23 Arterius Ltd. (UK) 24 Biotronik SE & Co. KG (Germany) 25 Boston Scientific Corporation (USA) 26 Bristol-Myers Squibb Company (USA) 27 Cedars-Sinai Medical Center (USA) 27 Cordis Corporation (USA) 28 Duke University (USA) 28 Elixir Medical Corporation (USA) 29 ELLA-CS, s.r.o. (Czech Republic) 32 Ethicon, Inc. (USA) 33 Eurocor GmbH (Germany) 34 GP Medical, Inc. (Australia) 35 JMS Co., Ltd. (Japan) 35 Kyoto Medical Planning Co., Ltd. (Japan) 36 Medtronic, Inc. (USA) 37 Poly-Med, Inc. (USA) 38 ProFibrix B.V. (The Netherlands) 39 Reva Medical Inc. (USA) 39 Tepha, Inc. (USA) 40 Xenogenics Corporation (USA) 41 3.5 Major Activities/Product Launches 42 First implantation of Elixir Medical’s DESolve® Novolimus Eluting Coronary Scaffold System in Europe 42 BIOTRONIK Reports Use of First–in–Human Use of Bioabsorbable Magnesium DREAMS Scaffold 42 Elixir Reports Outstanding 1-year Results for Safety and Efficacy for 100% Bioresorbable DESolve® Novolimus Eluting Coronary Scaffold System 43 Elixir's DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System Certified by CE 43 Asian Heart Institute Conducts Angioplasty with New Generation Biodegradable Stent 44 Elixir Medical Finalizes the Enrollment for the DESolve Nx Pivotal Trial Carried Out for Fully Bioresorbable Coronary Scaffold System 44 REVA Medical Presents the First Follow-Up Imaging Assessment of the ReZolve® Scaffold 45 Arterial Remodeling Technologies (ART) Announces First Human Use of Its Bioresorbable Stent 45 Biotronik Announces Positive Results from BIOSOLVE-I trial 45 American Heart Association Reports Igaki Tamai Biodegradable Stent Safe for Long-Term Treatment of Coronary Artery Disease 46 Reva Medical’s ReZolve™ Stent Bring a New Revolution to Cardiology: Claims to Stop Heart Attacks before they Occur with Resorbable Stents 46 S3V Vascular Technologies Introduces first Bioabsorbable Endovascular Drug Coated Stent "3V-Avatar"in India 47 Abbott Initiates Clinical Trial to Evaluate and compare Absorb™ Bioresorbable Vascular Scaffold and Metallic Drug Eluting Stent 48 Abbott Begins Clinical Trials for ABSORB™ BTK, to treat Below-the-Knee Limb Ischemia 48 UK Medical Launches the First Ever Biodegradable Esophageal Stent 49 Abbott Announces the Success of International Clinical Trial of 'ABSORB', a Bioresorbable Vascular Scaffold in Japan. 49 Arterius Ltd. Signs a New Research Collaboration 49 Abbott Announces the Success of Second Trial of 'ABSORB', a Bioresorbable Vascular Scaffold 50 Abbott Announces the CE Marking on ABSORB in Europe, World's First Drug Eluting Bioresorbable Vascular Scaffold 50 Biodegradable Stent Implanted in India 51 Xenogenics Completes the Acquisition of the Assets of Ideal BioStent 51 Biodegradable Heart Stent Study Findings 51 ART Raises US$ 8.5M for Biodegradable Stents 52 IGAKI-TAMAI’s Bioabsorbable Stent Gains CE Mark Status for Peripheral Artery 52 Abbott Develops Effective Bioabsorbable Stent 53 3.6 Biodegradable Stents – Market Outlook 54 4. PRODUCT TECHNOLOGY/RESEARCH 56 4.1 Introduction 56 Exhibit 9. Comparative Features - Bare Metal Stent, Drug Eluting Stent and Biodegradable Stent 56 Design and Composition 57 Raw Materials for Biodegradable Stents Synthesis 58 Biopolymers Used in Stents 58 Controlling properties 59 Mechanical performance 59 The chemistry of polymers 60 The selection of the materials 60 The steps in the processing 61 The degradations aspects 61 Exhibit 10. Characteristics of Widely Used Biodegradable polymers 61 Poly Lactic Acid 62 SR-PLA- Biodegradable Stents 63 Poly-Caprolactone 63 Polyglycolide 63 Biodegradable Metallic Stents 63 Iron-based Biodegradable Stents 64 Magnesium-based Biodegradable Stents 66 Fabrication of Biodegradable Stents 68 Exhibit 11. Biodegradable Stents – By Degradation Time and Biodegradable Material Used 68 Powder Metallurgy 69 Electroforming 69 Passivation Methods 70 Oxide Films 70 Electropolishing 70 Coatings 70 Nitinol & its Biocompatibility 71 Effect of Surface Passivation on Biocompatibility 71 Welding 73 Time Factor 73 Mechanical Property of Biodegradable Stents 74 Polymer Mechanical Property 74 Polymer Degradation 74 Comparison of Biodegradable Stents with Other Stents 75 Cost 75 Significance of Clinical Trials 76 Drug for Biodegradable Stents 76 Heparin 76 Sirolimus 77 Paclitaxel 77 Limitations 77 Advantages 77 Applications 78 Cardiovascular Disease 78 Ischemic Heart Disease 78 Congenital Heart Disease 79 Early Attempts to Treat CHD 79 4.2 Biodegradable Stents - Research Briefs 80 Biodegradable Magnesium Alloy for Medical Devices 80 A 59 year Old Implanted with Biodegradable Stent 80 Characteristics and Cyto-Compatibility of Biodegradable Polymer Film on Magnesium by Spin Coating 80 A Novel Radioplaque Biodegradable Stent for Pancreatobiliary Applications 81 Biodegradable Stent Found to be Safe for Long-term Therapy of Coronary Artery Disease 82 Biodegradable Stent proven to be Safe for Long-Term Treatment of Coronary Artery Disease 82 Biodegradable Stent and Hyper Granulation Causing Re-Stenosis Risk 83 Biodegradable Bifurcation Stents 83 Rabbit Airway Model Using New Biodegradable Polydioxanone Stents 84 Magnesium based bioabsorbable stents Inhibits Smooth Muscle Proliferation and Stimulates Endothelial Cells In Vitro 84 Biodegradable Stent for the Treatment of Benign Colorectal Anastomotic Stricture 85 In Vivo Study of Biodegradable Biliary Duct Stent 85 A New Potential Composite of MAO/PLLA using Modified Magnesium Alloy WE42 Developed 86 Use of Corrosion Model for Bioabsorbable Metallic Stents 87 New, Biodegradable Heart Stent Prove Safe in Trials 87 Clinical Follow-up Results of Biodegradable Stents (EXCEL™) and Durable Polymer Stent (CYPHER™) in Treating Coronary Artery Disease 87 Biodegradable Stents for Bronchial Stenosis Treatment 88 In Vivo Study of Biodegradable Poly (Trimethylene Carbonate-co-D, L-Lactide) Stent 88 Bio-Absorbable Stent for Treating CAD 89 Modeling of Deformation-Accelerated Breakdown of Polylactic Acid Biodegradable Stents 90 Biodegradable Stents for the First Time in India 90 The BEST (Biodegradable Esophageal Stent) study 91 Biodegradable Cardiovascular Stent Material Developed Using Electroformed Iron 91 Polydioxanone Biodegradable Stents for the Management of Benign Intrahepatic Bile Duct Strictures 92 Tomography Study of a Biodegradable Stents compared to Durable Polymer-Coated Limus –Eluting Stent 92 Coating Bio-Absorption and Chronic Bare Metal Scaffolding versus Fully Bio-Absorbable Stent 93 Researcher Develops Biodegradable Stent for Hearts Patients 93 Biodegradable Stent and Severe Epithelial Hyperplasia Complication 94 A Potential, Non-Randomized Multicenter Clinical Trial of Absorbable Magnesium Stents for Coronary Implants 94 Biodegradable Heart Stents 95 Absorbable Metal Stents 95 Drug-Eluting and Absorbable Stents Push Interventional Frontiers Separate Study Fine-Tunes Timing of Anti-Clotting Drugs 96 First Successful Implantation of a Biodegradable Metal Stent into the Left Pulmonary Artery of a Preterm Baby 99 Implantation of the First Absorbable Metal Stents (AMS) in Humans 99 Assessment of a Dissolvable Urethral Drainage Stent in a Swine Model 100 Biodegradable Stents – A Disappearing Act 101 Biodegradable Polyglycolic Acid Spiral Stent and Endoscopic Urethroplasty 102 V. CORPORATE DIRECTORY 103 VI. PATENTS INFORMATION 105
Our library has over 100000 reports on 1000s of topics
Over 100+ Fortune 500 companies rely on us
90,000+ people come to us for insights every month
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.